|Podcasts|April 18, 2023

Examining the Neurology/Neuromuscular Space

Sindhu Ramchandren, MD, Director, Clinical Leader, Neuroscience at Janssen, discusses the importance of having physicians involved in clinical trials, walks us through her career path and more.

In this episode of the Applied Clinical Trials podcast, we are joined by Sindhu Ramchandren, MD, Director, Clinical Leader, Neuroscience at Janssen. With experience as a principal investigator on neuromuscular trials, Ramchandren discusses the importance of having physicians involved in clinical trials. She also walks us through her career path and gives insight into her work on finding potential therapies for Myasthenia Gravis.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related to this article

November 4th, 2026

The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time

In Episode 4 of The Human Side of Clinical Trials, host Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., speaks with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about how capturing friction closer to the moment it happens can reveal unclear instructions, technology friction, and workarounds that retrospective surveys and debriefs tend to miss.

November 4th, 2026

ACT Brief: Community Research Financing Gaps, Neuroscience Endpoint Data, and Teva’s Biosimilar Deal

In today’s ACT Brief, we examine why community research needs lasting financing and infrastructure, how electronic outcome tools can strengthen neuroscience endpoints, and how Teva is licensing two biosimilars from Samsung Bioepis.

November 3rd, 2026

ACT Brief: Embedding AI Across Operations, Faster Trial Decisions, and Voceryq Approval

In today’s ACT Brief, we examine what changes when AI is embedded across clinical operations, why faster trial data isn’t yet producing faster decisions, and how FDA granted accelerated approval to a therapy for a rare airway disease.

November 2nd, 2026

ACT Brief: Community Research Policy Needs, Walmart Trial Centers, and Psoriatic Arthritis Approval

In today’s ACT Brief, we examine what policy changes would help community and rural institutions join research, how Walmart is expanding clinical trial centers into three more states, and how FDA approved Ilumya for adults with active psoriatic arthritis.

October 30th, 2026

ACT Brief: Community Research Access, Trustworthy AI Assistants, and Individualized Gene Editing Guidance

In today’s ACT Brief, we examine why community and rural patients lack access to research as a care option, what makes AI assistants trustworthy in regulated trials, and how FDA draft guidance could let gene editing therapies cover patient-specific variants.

October 29th, 2026

ACT Brief: Community Trial Access Technology, RBQM Infrastructure, and Digital Clone Use Cases

In today’s ACT Brief, we examine why anti-kickback guidance and EHR-integrated trial matching must work together in community settings, why real-time trials depend on mature risk-based quality management, and how pharma is applying digital clones to predict outcomes.

October 28th, 2026

ACT Brief: Legacy Trial Workflows, Medical Writing Talent Gaps, and Post-Exposure COVID Prevention

In today’s ACT Brief, we examine how legacy workflows pull community clinics away from patient care, why medical writing capacity depends on training rather than technology, and how an antiviral aims to prevent COVID-19 after exposure

October 27th, 2026

ACT Brief: Community Trial Cost Barriers, Measuring What Matters, and Prostate Cancer Approval

In today’s ACT Brief, we examine how cost barriers and site infrastructure limit participation in community trials, why endpoints should reflect what patients actually experience, and how the FDA expanded a prostate cancer combination to an earlier treatment setting.

Examining the Neurology/Neuromuscular Space

Related to this article

Trending on Applied Clinical Trials Online

Embedding AI Across the Clinical Operating Model: Q&A with Rajneesh Patil, Syneos Health

From Signal to Action: Why Faster Trial Data Isn’t Producing Faster Decisions

From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA

Beyond the Modernization Act: What It Takes to Make Community Research Infrastructure Permanent

ACT Brief: Embedding AI Across Operations, Faster Trial Decisions, and Voceryq Approval